Prostate Cancer Trials
Statuses
Locations
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 2101
ANZadapt
Phase II randomised controlled trial of patient-specific adaptive versus continuous Abiraterone or eNZalutamide in metastatic castration-resistant prostate cancer
Trial assessing whether adaptive (pause–restart) hormone treatment compared to continuous hormone treatment improves outcomes for people with advanced…
TYPE
Prostate
STATUS
Recruiting
LOCATION
NSW | VIC | QLD | WA | NZ
PROTOCOL #
ANZUP2205
DARO-LIPID
Randomised Phase 2 study of sphingosine kinase inhibitor (opaganib) in addition to darolutamide in people with poor prognostic metastatic castration …
Trial assessing whether adding a new treatment (opaganib) to standard therapy improves outcomes for a selected group of people with advanced, treatmen…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | Ireland | Canada | USA
PROTOCOL #
ANZUP 1801
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 1901
ENZA-p
A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in people with metastatic castration-resistant prostate cancer treated with enzalutamide.
Trial assessing whether adding a targeted radiation treatment (LuPSMA) to enzalutamide improves outcomes, and how PSMA PET/CT can help monitor disease…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | NT | SA | TAS | WA | NZ | UK | Ireland | Canada | USA
PROTOCOL #
ANZUP 1304
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | UK | Ireland | Belgium | USA | Spain | Austria | Slovenia
PROTOCOL #
ANZUP 1303
ENZARAD
Enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: a randomised phase III trial
Trial assessing whether adding enzalutamide to standard hormone therapy and radiation improves survival and quality of life for people with high-risk …
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | SA | WA
PROTOCOL #
ANZUP 2001
EVOLUTION
Phase II Study of Radionuclide 177Lu-PSMA Therapy versus 177Lu-PSMA in Combination with Ipilimumab and Nivolumab for people with Metastatic Castration Resistant Prostate Cancer
Trial assessing whether adding immunotherapy (ipilimumab and nivolumab) to a targeted radiation treatment (LuPSMA) improves outcomes for people with a…
TYPE
Prostate
STATUS
Recruiting
LOCATION
NSW | VIC | QLD
PROTOCOL #
ANZUP2102
GenI-AIRSPACE
Evaluating the effect of genomically informed treatment decision-making on long-term oncological outcomes for individuals diagnosed with intermediate …
Trial testing whether genomic test results can help guide decisions between active surveillance and treatment for people with favourable intermediate-…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
HREC/16/PMCC/130
proPSMA
A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy
Trial evaluating whether PSMA PET/CT scans can better detect cancer spread that may not be seen on standard scans and improve treatment decisions for …